F
$ Value
$15K
Shares
5,644
Price
$3
Filed
Oct 30
Insider
Name
Mahaney Paige
Title
Chief Scientific Officer
CIK
0002040313
Roles
Officer
Transaction Details
Transaction Date
2025-10-28
Code
F
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
99,356
Footnotes
Reflects the acquisition of shares of Common Stock upon vesting of a previously disclosed grant of restricted stock units ("RSUs"). The grant of RSUs was initially reported in Table I of the Form 4 filed by the Reporting Person on October 28, 2024. | Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person.
Filing Info
Mahaney Paige's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-14 | CCCC | M | $0 |
| 2026-02-14 | CCCC | F | $5K |
| 2026-02-13 | CCCC | A | $0 |
| 2025-10-28 | CCCC | M | $0 |
| 2025-10-28 | CCCC | F | $15K |
Other Insiders at CCCC (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
REYNO LEONARD
Chief Medical Officer
|
— | — | 2026-02-14 |
|
Hirsch Andrew
President & CEO
|
— | — | 2026-02-15 |
| GROGAN DONNA ROY | — | — | 2026-04-01 |
|
Schick Kelly
Chief People Officer
|
— | — | 2026-02-14 |
| Anderson Kenneth Carl | — | — | 2026-04-01 |
|
Boyle Scott N
Chief Business Officer
|
— | — | 2026-02-14 |
|
Adams Kendra
Chief Financial Officer
|
— | — | 2026-02-14 |
|
Mossler Mark
Chief Accounting Officer
|
— | — | 2026-02-14 |
|
Mahaney Paige
Chief Scientific Officer
|
— | — | 2026-02-14 |